Health TrialsbyHealthPanel

COMPARISON OF THREE TREATMENT MODALITIES IN MYOFASCIAL PAIN SYNDROME

ConditionMyofascial Pain Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorALİEMAN

About this trial

This study aims to compare the effectiveness of dry needling, extracorporeal shock wave therapy (ESWT), and pulsed radiofrequency (PRF) in patients with chronic musculoskeletal pain. The primary outcomes include pain intensity and functional status. Patients will be randomly assigned to different treatment groups, and outcomes will be evaluated before and after the interventions. The results of this study are expected to contribute to determining the most effective treatment method for pain management.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 18 and 65 years

Clinically diagnosed myofascial pain syndrome

Back pain lasting at least 3 months

Failure to respond to conservative treatments

Disqualifiers

History of cervical surgery or cervical disc pathology

Fibromyalgia

Shoulder pathologies

Coagulation disorders or use of anticoagulant therapy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Dry Needling

    Procedure/Surgery

    Dry needling applied to myofascial trigger points

  • Extracorporeal Shock Wave Therapy

    Procedure/Surgery

    Extracorporeal shock wave therapy applied to the painful area

  • Pulsed radiofrequency(PRF)

    Procedure/Surgery

    Pulsed radiofrequency applied to the target area for the treatment of myofascial pain syndrome

Treatment groups

60 Participants
are divided into 3 treatment groups
Group A: Dry Needling GroupExperimental treatment 1 intervention
Group B: ESWT GroupExperimental treatment 1 intervention
Group C: PRF GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Pain Intensity

Pain intensity will be assessed using the Numeric Rating Scale(NRS). Pain intensity will be assessed using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain severity.

Time frame
Baseline, 1 month, and 3 months after treatment

Secondary outcomes

1

Pressure Pain Threshold

Pressure pain threshold will be measured using algometry. Pressure pain threshold will be measured using an algometer (kg/cm²). Higher values indicate lower pain sensitivity and improved clinical condition.

Time frame
Baseline, 1 month, and 3 months after treatment
2

Neck Disability Index (NDI)

Functional status will be evaluated using the Neck Disability Index (NDI). Functional status will be assessed using the Neck Disability Index (NDI), with scores ranging from 0 to 50. Higher scores indicate greater functional impairment.

Time frame
Baseline, 1 month, and 3 months after treatment
3

Quality of Life (SF-12

Quality of life will be assessed using the Short Form-12 (SF-12) questionnaire. The SF-12 includes physical and mental component summary scores, with higher scores indicating better health-related quality of life.

Time frame
Baseline, 1 month, and 3 months after treatment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

ALİEMAN

Lead sponsor

Sakarya University

Sponsor institution

Source ClinicalTrials.gov
Apply now